Search

Subject disease-modifying therapies -- multiple sclerosis

1. Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Issue 4 (October 2021)

Authors:
Rico, Audrey; Ninove, Laetitia; Maarouf, Adil; Boutiere, Clémence; Durozard, Pierre; Demortiere, Sarah; Saba Villarroel, Paola Mariela; Amroun, Abdennour; Fourié, Toscane; de Lamballerie, Xavier; Pelletier, Jean; Audoin, Bertrand
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 7:Issue 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • disease-modifying therapies -- multiple sclerosis 1